|
|
Manuel Yepes, Maria Sandkvist, Elizabeth G. Moore, Thomas H. Bugge, Dudley K. Strickland, Daniel A. Lawrence
J Clin Invest. 2003;
112(10):1533
doi:10.1172/JCI19212
Abstract |
Full text
| PDF

T
he regulation of cerebrovascular permeability is critical for normal brain homeostasis, and the “breakdown” of the blood-brain barrier (BBB) is associated with the development of vasogenic edema and intracranial hypertension in a number of neurological disorders. In this study we demonstrate that an increase in endogenous tissue-type plasminogen activator (tPA) activity in the perivascular tissue following cerebral ischemia induces opening of the BBB via a mechanism that is independent of both plasminogen (Plg) and MMP-9. We also show that injection of tPA into the cerebrospinal fluid in the absence of ischemia results in a rapid dose-dependent increase in vascular permeability. This activity is not seen with urokinase-type Plg activator (uPA) but is induced in Plg–/– mice, confirming that the effect is Plg-independent. However, the activity is blocked by antibodies to the LDL receptor–related protein (LRP) and by the LRP antagonist, receptor-associated protein (RAP), suggesting a receptor-mediated process. Together these studies demonstrate that tPA is both necessary and sufficient to directly increase vascular permeability in the early stages of BBB opening, and suggest that this occurs through a receptor-mediated cell signaling event and not through generalized degradation of the vascular basement membrane.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(43)
| Title and authors |
Publication |
Year |
Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons
A. Machado, A. J. Herrera, J. L. Venero, M. Santiago, R. M. de Pablos, R. F. Villarán, A. M. Espinosa-Oliva, S. Argüelles, M. Sarmiento, M. J. Delgado-Cortés, R. Mauriño, J. Cano
|
ISRN Neurology
|
2011 |
Tissue-type plasminogen activator has a neuroprotective effect in the ischemic brain mediated by neuronal TNF-α
Woldeab B Haile, Jialing Wu, Ramiro Echeverry, Fang Wu, Jie An, Manuel Yepes
|
J Cereb Blood Flow Metab
|
2011 |
Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence
Denis Vivien, Maxime Gauberti, Axel Montagne, Gilles Defer, Emmanuel Touzé
|
J Cereb Blood Flow Metab
|
2011 |
Increased Serum PAI-1 Levels in Subjects with Metabolic Syndrome and Long-Term Adverse Mental Symptoms: A Population-Based Study.
Anne Huotari, Soili M Lehto, Leo Niskanen, Karl-Heinz Herzig, Jukka Hintikka, Heli Koivumaa-Honkanen, Tommi Tolmunen, Kirsi Honkalampi, Noora Kaikkonen, Heimo Viinamäki
|
Cardiovascular Psychiatry and Neurology
|
2010 |
The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity
George W J Harston, Brad A Sutherland, James Kennedy, Alastair M Buchan
|
J Cereb Blood Flow Metab
|
2010 |
Tissue-type plasminogen activator (t-PA) induces stromelysin-1 (MMP-3) in endothelial cells through activation of lipoprotein receptor-related protein
Y. Suzuki, N. Nagai, K. Yamakawa, J. Kawakami, H. R. Lijnen, K. Umemura
|
Blood
|
2009 |
Erythrocyte-Bound Tissue Plasminogen Activator is Neuroprotective in Experimental Traumatic Brain Injury
Sherman C. Stein, Kumkum Ganguly, Caitlin M. Belfield, Xiangsheng Xu, Edward W. Swanson, Xiao-Han Chen, Kevin D. Browne, Victoria E. Johnson, Douglas H. Smith, David G. LeBold, Douglas B. Cines, Vladimir R. Muzykantov
|
Journal of Neurotrauma
|
2009 |
Inhibition of Src activity decreases tyrosine phosphorylation of occludin in brain capillaries and attenuates increase in permeability of the blood–brain barrier after transient focal cerebral ischemia
Yuji Takenaga, Norio Takagi, Kazutoshi Murotomi, Kouichi Tanonaka, Satoshi Takeo
|
J Cereb Blood Flow Metab
|
2009 |
Can RAP save your brain?
A. J. G. Horrevoets
|
Blood
|
2009 |
Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact.
Benoit D Roussel, Richard Macrez, Amandine Jullienne, Véronique Agin, Eric Maubert, Luce Dauphinot, Marie-Claude Potier, Laurent Plawinski, Hervé Castel, Yannick Hommet, Josep Munuera, Joan Montaner, Manuel Yepes, Carine Ali, Denis Vivien
|
Brain
|
2009 |
|